Patent holders must start Unified Patent Court (UPC) proceedings on the merits within a certain period if they do not want to risk the revocation of provisional measures. The UPC has now clarified that filing the statement of...more
4/11/2025
/ Appeals ,
Deadlines ,
European Commission ,
Filing Deadlines ,
Germany ,
Litigation Strategies ,
Patent Infringement ,
Patent Litigation ,
Patent Ownership ,
Patents ,
Pharmaceutical Patents ,
Preliminary Injunctions ,
Unified Patent Court
Ortovox Sportartikel GmbH v. Mammut Sports Group AG/GmbH (UPC_CFI_16/2024), Düsseldorf Local Division (January 14, 2025) ORD_63219/2024.
Anyone developing or marketing an innovative product will want to ensure that they do...more
In a landmark decision Fives ECL, SAS v. REEL GmbH on January 16, 2025, the Court of Appeal (CoA) of the Unified Patent Court (UPC) clarified the jurisdictional boundaries of the UPC. This decision has far-reaching...more
4/2/2025
/ Appeals ,
Damages ,
EU ,
Germany ,
Intellectual Property Protection ,
Jurisdiction ,
Member State ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Unified Patent Court
In this note, we will discuss the latest decisions on the merits from the Dutch patent court on the matter of plausibility and inventive step. These were handed down in two cases (BMS v Sandoz and BMS v Teva) on 30 October...more
11/15/2024
/ Appeals ,
EU ,
Inventions ,
Netherlands ,
Patent Applications ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Technology ,
Teva v Sandoz ,
Unified Patent Court
On 18 October 2023, the President of the Court of First Instance of the UPC issued an order changing the procedural language from Dutch to English (the language of the patent at issue).
The Court weighed the interests of...more
In this episode of our Exclusively Life Sciences webinar series, our experts from our EU team will share best practices for innovators to protect their competitive advantage when generics enter the market....more